CENRIFKIPriority claimed from 09/02/2022; Application No. : 97259041 ;United States of America (Class 5)
#5561880
Application Number:5561880
Status: Unknown
Class:5
Applicant:PRINCIPIA BIOPHARMA INC.
Filing Date:Mon, 08 Aug 2022
In Progress
Is this your trademark application?
"CENRIFKIPriority claimed from 09/02/2022; Application No. : 97259041 ;United States of America" is still moving through the registration pipeline. Most applications hit at least one hurdle — objection, opposition or a hearing — and deadlines at each stage are short. Get notified the moment the status changes.
Trademark Information
| Trademark | CENRIFKIPriority claimed from 09/02/2022; Application No. : 97259041 ;United States of America |
| Trademark Type | Wordmark |
| Class | 5 |
| Application Number | 5561880 |
| Nature/Scope of business | Pharmaceutical preparations for the treatment of multiple sclerosis |
| Publication | In Journal No. 2087 |
| Status | Unknown |
| Applicant: | PRINCIPIA BIOPHARMA INC. |
| Applicant Address | 55 Corporate Drive, Bridgewater, New Jersey, 08807 United States of America A Delaware Corporation, USA |
| Jurisdiction | DELHI |
| Agent | REMFRY & SAGAR |
| Agent Address | REMFRY HOUSE AT THE MILLENNIUM PLAZA SEC 27, GURGAON 122009, NEW DELHI NATIONAL CAPITAL REGION INDIA |
Frequently Asked Questions
Who is the owner of trademark CENRIFKIPriority claimed from 09/02/2022; Application No. : 97259041 ;United States of America? ▾
The trademark application number 5561880 is owned by PRINCIPIA BIOPHARMA INC..
Which class does trademark CENRIFKIPriority claimed from 09/02/2022; Application No. : 97259041 ;United States of America belong to? ▾
Trademark application number 5561880 is filed under Class 5, which relates to the specified goods and services.
Who is the trademark agent for application 5561880? ▾
The trademark agent associated with application number 5561880 is REMFRY & SAGAR.
Was trademark CENRIFKIPriority claimed from 09/02/2022; Application No. : 97259041 ;United States of America published in the journal? ▾
Yes, trademark application number 5561880 was published in Journal No. 2087.
What is trademark CENRIFKIPriority claimed from 09/02/2022; Application No. : 97259041 ;United States of America? ▾
Trademark application number 5561880 relates to "Pharmaceutical preparations for the treatment of multiple sclerosis".
File Trademark at Just ₹1,499 + Govt Fees
Get your trademark registered with expert guidance. Limited time offer!
File NowExpert Consultation
Quick Processing
100% Support
Free Report
Get Detailed Trademark Report
Comprehensive analysis of your trademark search delivered to your phone
What you'll get:
- Complete trademark analysis
- Conflict assessment
- Registration guidance
15,000+Trademarks Filed
98%Success Rate
Govt Authorized
ISO Certified